White Paper: Accelerating Pharma Innovation and Drug Discovery with 5D Multiomics

Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimize costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data.

AVITI24™ 5D multiomics platform offers a new path by capturing RNA, protein, morphology, spatial resolution, and dynamic changes—all in a streamlined, customizable workflow.

Download the white paper to explore:

  • How 5D multiomics accelerates hit identification, target and biomarker discovery, and mechanism of action studies
  • Case studies on TKI resistance and CRISPR screening using AVITI24 and Direct In Sample Sequencing (DISS)
  • How AVITI24 saves time, reduces risk, and improves efficiency

Download the white paper

By submitting this form you agree to our Privacy Policy and Terms and Conditions.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.